Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Main Page: Difference between revisions

From Simon Harper
No edit summary
No edit summary
 
(48 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[Category:About]]
<div style="float: right; width: 50%; background-color: white; padding: 5px 5px 5px 5px; border-style: solid; border-width: thin; margin-left: 10px;">
In Autumn 2018 my Granddaughter (then 16 months old) became a person with Type 1 Diabetes (<code>T1DM</code>). Why this autoimmune condition occurs is not really clearly understood at present. At that time I could see how my work could be useful in T1DM and so I pivoted away from my <pastwork and focused my entire research portfolio (except accessibility) to T1DM, recruiting 8 Doctoral Candidates (including an NHS clinician and NHS Dietitian), creating a multi-disciplinary team across the NHS, Diabetes UK, FBMH, and the Manchester Diabetes Institute; setting up a pipeline for this research by building a start-up in stage 3 with UoMInnovationFactory securing early funding for our initial pilots; and expanding grant income, via a Wellcome Trust Access to Expertise, with NIHR and MRC applicants slated for the end of this year and the beginning of next.


== About ==
==== [[File:binoculars-fi.png|32px|]] Find Me On ====
<ul style="list-style-type:none;">
<li>[[File:ResearchGate_icon_SVG.svg|link=https://www.researchgate.net/profile/Simon-Harper-2|ResearchGate]] [https://www.researchgate.net/profile/Simon-Harper-2 ResearchGate]
<li>[[File:Bluesky_Logo.svg|32px|link=https://bsky.app/profile/sharpic.bsky.social|BlueSky]] [https://bsky.app/profile/sharpic.bsky.social BlueSky]
<li>[[File:Linkedin-png-linkedin-icon-1600.png|32px|link=https://www.linkedin.com/in/sharpic/|LinkedIn]] [https://www.linkedin.com/in/sharpic/ LinkedIn]
<li>[[File:Shield of the University of Manchester.svg|32px|link=http://www.manchester.ac.uk/research/simon.harper/|University of Manchester]] [http://www.manchester.ac.uk/research/simon.harper/ UoM Research Profile]
<li>[[File:ORCID iD.svg|32px|link=http://orcid.org/0000-0001-9301-5049|ORC-ID]] [http://orcid.org/0000-0001-9301-5049 ORC-ID]
<li>[[File:Google Scholar logo.svg|32px|link=http://scholar.google.co.uk/citations?user=SQEdResAAAAJ|Google Scholar]] [http://scholar.google.co.uk/citations?user=SQEdResAAAAJ Google Scholar]
<li>[[File:Octicons-mark-github.svg|GitHub|32px|link=https://github.com/sharpic]] [https://github.com/sharpic GitHub]
<li>[[File:The Conversation icon.png|32px|link=https://theconversation.com/profiles/simon-harper-2244542|The Conversation]] [https://theconversation.com/profiles/simon-harper-2244542 The Conversation]
<li>
[[File:Solid_white.svg|PGPKeys|32px|link=http://pgp.mit.edu/pks/lookup?op=get&search=0x74036D2D1408035A]] [http://pgp.mit.edu/pks/lookup?op=get&search=0x74036D2D1408035A <code>PGP Public Key</code>]
</ul>
</div>
[[wikipedia:TL;DR|TL;DR]] I'm a researcher professor working at the [[wikipedia:University_of_Manchester|University of Manchester]] in the [[wikipedia:Department_of_Computer_Science,_University_of_Manchester|Department of Computer Science]]. I've been working in [[wikipedia:Type_1_diabetes|Type 1 Diabetes (T1D/T1DM)]] technology since 2018, specifically focusing on glucose and carbohydrate dosing (I'm leaving insulin dosing to the large corporations) and in-silico simulation as applied to the real world. The technology focuses an behavioural (digital) phenotyping assuming that we are habitual (or at least repetitive) and that there is a transitive relationship between blood glucose and behaviour.


I am a Professor in Computer Science, Head of Postgraduate Research for Computer Science, a University Senator, a Member of the General Assembly and a member of the University Examinations Board. Professionally, I am a Fellow of the British Computer Soc., a Fellow of the Institute of Engineering Technology, and an Association of Computing Machinery Distinguished Scientist.
All of my work is focused an trying to move research to technology in peoples hands as fast as possible which is why I have the Melontech startup for research prototypes, and an independent side project.


My work is centred on understanding, predicting and influencing a user’s behaviour in the real-world and through interfaces and information, while taking into account cognitive, behavioural, perceptual and technological factors. My contributions lie in the development of adaptive user models of extreme users and/or extreme environments.
Before my work in T1DM I spent 25 years in accessibility research specifically around profound blindness and the World Wide Web, with some forays into [[Parkinson's Disease]], [[Healthcare]], and [[Visual Attention]].  


=== Grants and Translation ===
You can find out more about my [[Type 1 Diabetes]] and [[Web Accessibility]] work, including my [[:Category:The_Friday_Night_Experiments|Friday Night Experiments]], or more [[Main:About|about me]], and [[More_About_Me|what I biases I have]].
I've been an Investigator on 19 grants (10 as PI). Having ongoing projects and relationships with: BBC R&amp;D; Google; IBM R&amp;D; Intel; CTIC-Telefonica; Ove Arup Partners; Age Concern; Buttercup Telecommunications; and Docobo, these contributions have not only stayed within the academic community but have made their way into the DNA of the Web via browsers (chromium), software tools (eclipse ACTF) and internationalstandards (W3C UAAG 2.0 / W3C RDWG Symposia). I have led the ACM Special Interest Group on the Web for 2 terms and have led the W3C (the International Standards Body for the Web) Research and Development working group for 4 years making decisions by building consensus when creating web standards (my working being commended as “instrumental to the development of the Web” by Sir Tim Berners Lee).


=== Past Work ===
<!-- <rss max=4>https://wikimediafoundation.org/news/feed/</rss>
 
-->
My particular interest is in Web Accessibility with specific regard to profound blindness and visual disability. My work is centred around building computational models of human behaviour and includes understanding, predicting, and influencing a user’s interactions and flow through interfaces and information, while taking into account neurophysiological, cognitive, behavioural, perceptual, and technological factors. In this case, my contributions lay along two paths. The first investigates ‘facilitating access and enhancing interactive Web behaviours’, while the second focuses on ‘understanding, evaluating, and modifying the Web experience’.
[[category:General]]
 
I co-founded the Web4All Conference Series (now in its 11th Edition) and organised the first four (2004-2007 inc.) as General Chair; Steering Committee – International ACM SIGACCESS Conference on Computers and Accessibility; Steering Committee – International Cross-Disciplinary Conference on Web Accessibility; and Steering Committee – International ACM Conference on Hypertext and Hypermedia. Programme Chair for ACM ASSETS (2006); Submissions Chair for the WWW Conference (2006) and Accessibility Chair for the 2012 edition; ACM Student Research Competition Grand Finals Judge (2012), General Chair for ACM Hypertext (2007) and ACM ASSETS (2008) and is also a member of the steering committee for these two conferences. I have served on the programme committees, doctoral consortium panels, and review panels for a number of international conferences including ACM HT, WWW, ISWC, ACM CHI, UIST, ACM ASSETS, and ACM SAC. I have guest edited the New Review of Hypermedia and Multimedia; Journal of Web Engineering; Journal of Disability and Rehabilitation, and Universal Access in the Information Society. He currently reviews for ACM Transactions on Computer Human Interaction, ACM Transactions on the Web, Elsevier Journal of Web Semantics, and IEEE Internet Computing.

Latest revision as of 17:25, 6 March 2025

TL;DR I'm a researcher professor working at the University of Manchester in the Department of Computer Science. I've been working in Type 1 Diabetes (T1D/T1DM) technology since 2018, specifically focusing on glucose and carbohydrate dosing (I'm leaving insulin dosing to the large corporations) and in-silico simulation as applied to the real world. The technology focuses an behavioural (digital) phenotyping assuming that we are habitual (or at least repetitive) and that there is a transitive relationship between blood glucose and behaviour.

All of my work is focused an trying to move research to technology in peoples hands as fast as possible which is why I have the Melontech startup for research prototypes, and an independent side project.

Before my work in T1DM I spent 25 years in accessibility research specifically around profound blindness and the World Wide Web, with some forays into Parkinson's Disease, Healthcare, and Visual Attention.

You can find out more about my Type 1 Diabetes and Web Accessibility work, including my Friday Night Experiments, or more about me, and what I biases I have.